Testimonials

Background stories of how others approached and experienced their European Horizon funding trajectory.

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Published on | 6 months ago

Programmes Health

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article for details 
Other available testimonials

Testimonial

image of ATHENA - Cybersecurity for the water sector

ATHENA - Cybersecurity for the water sector

The ATHENA project addresses emerging risks for the water sector in operational technology created by digitalisation. The project responds to Digital Europe call DIGITAL-ECCC-2022-CYBER-03-UPTAKE-CYBERSOLUTIONS – Uptake op Innovative Cybersecurity Solutions. The project started in September 2023 and will run until November 2026. De Vlaamse Waterweg - The Flemish Waterway participates in the project to enhance the resilience of the organisation by co-developing targeted training modules for operational technology environments.